HK1044467B - 多環噻唑體系用於製備預防或治療肥胖的藥物的用途 - Google Patents

多環噻唑體系用於製備預防或治療肥胖的藥物的用途

Info

Publication number
HK1044467B
HK1044467B HK02106057.5A HK02106057A HK1044467B HK 1044467 B HK1044467 B HK 1044467B HK 02106057 A HK02106057 A HK 02106057A HK 1044467 B HK1044467 B HK 1044467B
Authority
HK
Hong Kong
Prior art keywords
preventing
treating obesity
producing medicaments
thiazole systems
polycyclic thiazole
Prior art date
Application number
HK02106057.5A
Other languages
English (en)
Other versions
HK1044467A1 (en
Inventor
G‧傑恩
K‧蓋森
H-J‧蘭格
M‧畢克爾
Original Assignee
阿文蒂斯藥物德國有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿文蒂斯藥物德國有限公司 filed Critical 阿文蒂斯藥物德國有限公司
Publication of HK1044467A1 publication Critical patent/HK1044467A1/xx
Publication of HK1044467B publication Critical patent/HK1044467B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK02106057.5A 1999-02-26 2002-08-20 多環噻唑體系用於製備預防或治療肥胖的藥物的用途 HK1044467B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19908535A DE19908535A1 (de) 1999-02-26 1999-02-26 Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
PCT/EP2000/000928 WO2000051579A2 (de) 1999-02-26 2000-02-05 Verwendung von polycyclischen thiazol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas

Publications (2)

Publication Number Publication Date
HK1044467A1 HK1044467A1 (en) 2002-10-25
HK1044467B true HK1044467B (zh) 2004-08-20

Family

ID=7899079

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106057.5A HK1044467B (zh) 1999-02-26 2002-08-20 多環噻唑體系用於製備預防或治療肥胖的藥物的用途

Country Status (15)

Country Link
US (1) US6329407B1 (zh)
EP (1) EP1156805B1 (zh)
JP (1) JP4728482B2 (zh)
KR (1) KR20010103775A (zh)
CN (1) CN1141940C (zh)
AT (1) ATE273006T1 (zh)
AU (1) AU766813B2 (zh)
BR (1) BR0008519A (zh)
CA (1) CA2362364A1 (zh)
DE (2) DE19908535A1 (zh)
ES (1) ES2221836T3 (zh)
HK (1) HK1044467B (zh)
PT (1) PT1156805E (zh)
WO (1) WO2000051579A2 (zh)
ZA (1) ZA200106439B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
FR2870742B1 (fr) * 2004-05-28 2008-03-14 Expanscience Laboratoires Sa Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
PE20091720A1 (es) * 2008-03-31 2009-11-26 Genentech Inc Compuestos de benzopirano y benzoxepina como inhibidores de pi3k
PL2483278T3 (pl) 2009-09-28 2014-05-30 Hoffmann La Roche Związki benzoksazepinowe stanowiące inhibitor pi3k i ich zastosowanie w leczeniu nowotworu
MX2012003641A (es) 2009-09-28 2012-04-30 Hoffmann La Roche Compuestos de benzoxepina inhibidores de la pi3x y metodos de uso.
BR112013024122A2 (pt) 2011-03-21 2019-09-24 Hoffmann La Roche compostos de benzoxazepina seletivos para p110 delta pi3k e métodos de uso
US10689955B1 (en) 2019-03-05 2020-06-23 SWM International Inc. Intelligent downhole perforating gun tube and components
US11078762B2 (en) 2019-03-05 2021-08-03 Swm International, Llc Downhole perforating gun tube and components
US11268376B1 (en) 2019-03-27 2022-03-08 Acuity Technical Designs, LLC Downhole safety switch and communication protocol
US11619119B1 (en) 2020-04-10 2023-04-04 Integrated Solutions, Inc. Downhole gun tube extension

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
HUT64224A (en) * 1991-08-13 1993-12-28 Dana Farber Cancer Inst Inc Process for the production of the medical preparatives containing rodacimin applicable for treatment of cancer
WO1994006791A1 (en) * 1992-09-14 1994-03-31 Yamanouchi Pharmaceutical Co., Ltd. Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same
MX9603998A (es) * 1994-03-11 1997-12-31 Yamanouchi Pharma Co Ltd Agonista receptor de 5-ht3, derivado de tiazol novedoso e intermediario del mismo.
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen

Also Published As

Publication number Publication date
PT1156805E (pt) 2004-10-29
ES2221836T3 (es) 2005-01-16
EP1156805B1 (de) 2004-08-11
JP2002538101A (ja) 2002-11-12
JP4728482B2 (ja) 2011-07-20
DE50007381D1 (de) 2004-09-16
EP1156805A2 (de) 2001-11-28
US6329407B1 (en) 2001-12-11
BR0008519A (pt) 2001-11-13
WO2000051579A3 (de) 2001-01-11
CN1341021A (zh) 2002-03-20
DE19908535A1 (de) 2000-08-31
ATE273006T1 (de) 2004-08-15
AU2441700A (en) 2000-09-21
KR20010103775A (ko) 2001-11-23
CN1141940C (zh) 2004-03-17
WO2000051579A2 (de) 2000-09-08
CA2362364A1 (en) 2000-09-08
HK1044467A1 (en) 2002-10-25
AU766813B2 (en) 2003-10-23
ZA200106439B (en) 2002-03-06

Similar Documents

Publication Publication Date Title
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
IL150150A0 (en) 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
HK1044467A1 (en) Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity
HK1045809A1 (en) Utilization of polycyclic 2-amino-thiazole systemsin the production of medicaments for prophylaxis or treatment of obesity.
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
PT1157015E (pt) Utilizacao de sistemas 2-amino-triazole policiclicos para a preparacao de medicamentos para tratamento de perturbacoes lipometabolicas, da obesidade e da diabetes tipo ii
AU2162202A (en) Antitumor therapy comprising distamycin derivatives
WO2001016096A3 (de) Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie
HK1042300A1 (en) Polycyclic thiazole systems and their utilization as anorectics.
YU30602A (sh) Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima
MXPA04001858A (es) Uso de derivados de sistemas de indan-1-ol c2-substituidos para producir medicamentos para la profilaxis o el tratamiento de la obesidad.
IL160605A (en) Use of c2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity
WO2001021620A3 (de) Aminderivate von benzo-4,5-thieno-2,3-d-pyrimidinen
PT1263444E (pt) Aplicacao de derivados de xantina para a preparacao de um medicamento destinado a prevencao ou ao tratamento da osteoporose
HK1042299A1 (en) Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments.
WO2005117847A3 (en) Methods and compounds for the treatment of neoplasms

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080205